MENA Healthcare Competitive Intelligence Case Study: Moving into Saudi Arabia and Dubai
A healthcare organisation had a strong reputation at home. Solid clinical outcomes. A trusted brand. A management team that had grown the business steadily for over a decade. They had watched the Gulf markets from a distance for years, seen the investment, seen the demand, and decided it was time to move.
They were not prepared for what they found.
Background
Our client provided specialist healthcare services to private and corporate clients across Europe. The leadership team had identified Saudi Arabia and Dubai as priority expansion markets. Both had undergone major government investment in medical infrastructure. Both had growing populations with rising expectations of private healthcare quality. And both were actively seeking international providers to raise standards.
The firm had the clinical capability. What it lacked was any real understanding of who it would be competing against, how those competitors operated, and what local buyers and commissioners actually looked for when selecting a provider.
They had spent six months reading reports and attending conferences. They still did not feel ready. That is when they called us.
What Was Happening
The Gulf healthcare market looks open from the outside. The reality is more complicated.
In Saudi Arabia, the Ministry of Health and the Council of Cooperative Health Insurance govern much of what a private provider can do, who it can treat, and how it can bill. Licensing requirements are considerable. The Saudi Commission for Health Specialities controls the recognition of clinical qualifications. A European-trained consultant does not automatically have the right to practise.
In Dubai, the Dubai Health Authority runs a parallel licensing system. The private healthcare market is well-developed and competitive. Several large hospital groups dominate. International brands have entered, some successfully, some not.
Our client had identified three competitors already operating across both markets. We refer to them here as Competitor A, Competitor B, and Competitor C.
Competitor A was a large European hospital group with facilities in Dubai and a partnership arrangement in Riyadh. It had been in the region for seven years. It was well known among expatriate communities and had recently begun targeting high-net-worth Saudi nationals seeking European clinical standards without travelling to Europe.
Competitor B was a US-based healthcare brand with a single facility in Dubai Healthcare City. It traded heavily on its American credentials and had built a strong reputation in oncology and cardiology. Its pricing was at the top of the market.
Competitor C was a regional operator headquartered in Dubai with facilities in both the UAE and the Kingdom. It was less well known internationally but deeply embedded in local networks. It had relationships with government entities, insurance companies, and corporate clients that the international players found hard to replicate.
The client was entering a market with incumbent players, complex regulations, and buyers whose decision-making was shaped by factors not reflected in any public report.
Key Questions
Before the client could build a credible plan, it needed answers to five questions.
How did commissioners, insurers, and corporate buyers in each market actually select healthcare providers? What were the real barriers to entry beyond the published regulatory requirements? Where were Competitors A, B, and C strong, and where were they exposed? What did local patients and corporate clients want that existing providers were not delivering? And what would it cost, in time and resources, to build the kind of local presence needed to compete?
What We Did
We ran a ten-week intelligence programme across both markets.
Our team conducted primary research conversations with procurement leads at large corporates, insurance executives, and healthcare commissioners in both Saudi Arabia and Dubai. These were structured conversations, conducted in confidence, designed to understand how decisions were made from the inside.
We ran a mystery shopping exercise against all three competitors. We contacted each as a prospective corporate client, reviewed their sales and onboarding processes from the first enquiry through to the proposal, and documented everything. Response times, quality of materials, how they handled questions about clinical governance, how they priced group plans, and how they managed the conversation when pushed on specific clinical capabilities.
We also spoke with local licensing consultants, healthcare recruitment specialists, and former employees of two of the three competitors. These conversations gave us a ground-level view that no regulatory document or annual report could provide.
In Saudi Arabia, we paid particular attention to the Sehhaty platform and the implications of the National Health Information Centre’s data requirements. In Dubai, we examined the Dubai Health Authority’s licensing pathway for new international entrants and looked at where that process had caught out previous market entrants.
The Results
The research changed the client’s view of both markets.
In Dubai, the opportunity was real but narrow. The expatriate market was well served. The high-net-worth local market was competitive and relationship-dependent. The corporate market was the most available entry point, but it required insurance panel recognition before most corporate clients would consider a new provider. Getting onto those panels took time and required local relationships that took longer still to build.
Competitor B
Competitor B was performing well in its specialist areas but had a visible gap in primary care and occupational health. Several corporate buyers we spoke with expressed frustration that their relationship with Competitor B could not cover the full range of services their employee population needed. That gap was specific and exploitable.
Competitor A
Competitor A was strong on brand but had a reputation for inconsistent service quality at its Dubai facility. Three separate sources mentioned the same concern without prompting. It was not a single bad experience. It was a pattern.
Competitor C
Competitor C was the toughest competitor in Saudi Arabia. Its local relationships were deep, and its insurance panel coverage was extensive. Competing against it directly, at least in the early stages, would be costly and slow. The smarter approach was to find the segments it did not serve well and own those first.
The mystery shopping results were instructive. Competitor A took four days to respond to a corporate enquiry and sent a generic brochure. And competitor B responded within 48 hours with a detailed, personalised proposal, but did not follow up when we went quiet. Competitor C responded within a day and followed up three times over the next two weeks. It was understood that the sale required persistence.
The regulatory picture in Saudi Arabia was more complex than the client had anticipated. The licensing timeline for a new facility was 18 to 24 months. The client had been planning for 12. That single piece of intelligence materially changed its investment timeline and cash flow projections.
Our Recommendations
We gave the client six recommendations.
Enter Dubai first. The regulatory pathway was faster, the market was more familiar with international providers, and the corporate insurance route offered a clear first revenue stream. Saudi Arabia remained the larger long-term opportunity, but it required more preparation and more time.
Target the occupational health and primary care gap that Competitor B had left open. Several large corporations had already expressed a need for a provider capable of handling both specialist referrals and everyday employee healthcare within a single relationship. The client could position itself to fill that role.
Begin the Dubai Health Authority licensing process immediately. Every week of delay added to the timeline before the first patient could be seen.
Hire locally before opening. The client’s instinct had been to transfer existing clinical and management staff from Europe. The research made clear that local hiring, particularly at the relationship-facing level, was a significant factor in how corporate buyers evaluated new providers. A team with no local faces would start at a disadvantage.
In Saudi Arabia, pursue an alliance rather than a standalone facility for the first two years. A joint venture or licensing arrangement with an established local operator would provide regulatory cover, insurance panel access, and local network access far faster than building from scratch.
Do not compete with Competitor C on its own ground. Find the segments it ignores, own them, and build from there.
Conclusions
The client had arrived at this market with faith in its clinical capability. That confidence was justified. The capability was real. The research made clear that clinical capability was one factor among many, and in the Gulf, it was rarely the deciding factor.
Relationships, regulatory readiness, local presence, and an understanding of how decisions were actually made — these were the factors that separated the providers winning business from those waiting for it.
The client modified its timeline, revised its entry approach, and began the Dubai licensing process three weeks after receiving the final report. It appointed a Dubai-based healthcare director four months later. The first corporate contract in Dubai was signed fourteen months after the initial research programme concluded.
Saudi Arabia followed 18 months later, through a partnership with a Riyadh-based hospital group that the research had identified as the strongest available local partner.
Neither market had been easy. Both were possible because the client went in knowing what they were actually dealing with.
About Octopus Intelligence, the UK and Dubai-based Competitive Insights Consultancy
Octopus is a global competitive insights consultancy with offices in the UK and Dubai.
Our Dubai team works with businesses competing across the Gulf and those looking to enter the region successfully. We combine deep human intelligence with rigorous secondary research to give MENA clients a clear picture of their competitive landscape. Who is moving, how, and why.
We work with MENA and UAE-based businesses across technology, healthcare, financial services, manufacturing, and private equity. Our work covers competitor profiling, market mapping, strategic early warning, and deal-level intelligence for investors and acquirers.
Outsmart your competition. Make the unknown known. Octopus helps you gain clarity in complex markets. With clients and tentacles around the MENA, we deliver sharp, actionable competitive insights through a blend of deep primary (talking to people) and secondary research. If you’re looking to make smarter decisions, beat the competition, and reduce uncertainty, we’re the partner you want on your side.
If you compete in the Gulf and want sharper answers, contact our Dubai team below:
mohamed@octopusintelligence.com | Executive Director – MENA | +971 56 535 3198 | Dubai Digital Park, Dubai Silicon Oasis, Dubai, United Arab Emirates
